News Releases

The information set forth in each press release posted on this page was factually accurate on the date it was issued. While these press releases remain on the Company's website, the Company assumes no duty to update the information to reflect subsequent developments. Consequently, readers of the press releases should not rely upon the information as current or accurate after their issuance dates.

Date Title
08/09/22
Charles River Laboratories is First CDMO in North America to Receive EMA Approval to Commercially Produce an Allogeneic Cell Therapy Drug Product
08/03/22
Charles River Laboratories Announces Second-Quarter 2022 Results
07/11/22
Charles River Laboratories Schedules Second-Quarter 2022 Earnings Release and Conference Call
06/28/22
Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
06/23/22
Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
06/13/22
Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A
06/06/22
Charles River Laboratories to Participate in Jefferies and William Blair Conferences
05/04/22
Charles River Laboratories Announces First-Quarter 2022 Results
04/27/22
Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets
04/13/22
Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call
04/07/22
Charles River Laboratories Publishes 2021 Corporate Citizenship Report
04/06/22
Charles River Laboratories Acquires Explora BioLabs
03/28/22
Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial Officer
02/16/22
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
02/03/22
Charles River Laboratories Announces Wind Contract with Repsol for European Operations
01/27/22
Charles River Expands Strategic Partnership With SAMDI Tech
01/20/22
Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call
01/19/22
Charles River and Valo Health Announce Strategic Partnership to Provide Clients with Access to AI-Enabled Drug Discovery Solutions
01/11/22
Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
01/06/22
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference

Featured Report

2021 Annual Report (PDF)

Charles River Corporate Citizenship Report
View PDF
Print PDF